ESOT and ELITA are part of a joint initiative on the impact of COVID-19 on liver transplantation, aiming to explore how patients, healthcare professionals, and liver transplant centres across the world are affected – in their clinical care and waiting-list management. To this end, a survey launched in September 2020 has been sent to more
Category: Liver
ESOT Transplant Fellowship 2021 – Application deadline 15|10|2020
We are pleased to announce the ESOT Grants Programme for 2021! The application deadline is October 15th 2020.
Join our dedicated COVID-19 Open Forum
At this challenging time ESOT has created a dedicated online forum for transplant professionals to discuss experiences, offer recommendations and share resources linked to COVID-19. The forum is FREE of charge and open to all transplant professionals. Now, more than ever, we are #StrongerTogether. JOIN THE COVID-19 DISCUSSION ESOT Transplant Live subscribers can access the forum using their
The Hepatologist in a Liver Transplant Program (HLTP) Course 2021
The course has the main objective of expanding the knowledge related to liver transplantation, sensitizing the trainers in Hepatology and the young specialists to the main issues and to multidisciplinary approaches, thus increasing the interest in this setting, the ability of an adequate referral of potential liver candidates and satisfactory clinical skills. 5th Hepatologist in
ESOT works with patients in exciting new initiative
Building on past work with transplant patient organisations throughout Europe to foster cooperation between healthcare professionals and patients and to broaden patient participation in its own activities, ESOT is pleased to announce the launch of the Patient Inclusion Initiative. During the ESOT 2019 congress, ESOT hosted a meeting of 19 transplant patient organisations from 13
The COVID-19 Pandemic: Lessons learnt from Italy
The third webinar in the ESOT series devoted to the COVID-19 pandemic will focus on Italy, the first European country hit by the virus and one of the most heavily impacted countries overall. Our speakers, who have been on the front lines in the management of the pandemic, will share their experience and insights with
COVID-19 Response ELITA-ELTR registry and studies
The COVID-19 pandemic brought transplantation to a global standstill. Since February, 2020, healthcare providers implemented a radical and focused response to the pandemic, prioritizing organizational readiness and resource re-allocation to meet the anticipated influx of patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Many services, including solid organ transplantation, were suspended as intensive